FDA guidance aims to clarify device enhancements, recalls

02/26/2013 | MassDevice.com (Boston)

Draft guidance released by the FDA aims to clarify scenarios where changes to medical device design warrant a recall and help medtech firms differentiate those cases from product enhancements that do not constitute a recall. The guidance also outlines the regulatory standards for reporting a recall or product enhancement.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY